{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:08:06Z","timestamp":1790690886830,"version":"4.1.0"},"reference-count":115,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Laminopathies are a heterogeneous group of rare diseases caused by genetic mutations in the LMNA gene, encoding A-type lamins. A-type lamins are nuclear envelope proteins which associate with B-type lamins to form the nuclear lamina, a meshwork underlying the inner nuclear envelope of differentiated cells. The laminopathies include lipodystrophies, progeroid phenotypes and striated muscle diseases. Research on striated muscle laminopathies in the recent years has provided novel perspectives on the role of the nuclear lamina and has shed light on the pathological consequences of altered nuclear lamina. The role of altered nicotinamide adenine dinucleotide (NAD+) in the physiopathology of striated muscle laminopathies has been recently highlighted. Here, we have summarized these findings and reviewed the current knowledge about NAD+ alteration in striated muscle laminopathies, providing potential therapeutic approaches.<\/jats:p>","DOI":"10.3390\/cells9102248","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T09:12:58Z","timestamp":1602061978000},"page":"2248","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Need for NAD+: Focus on Striated Muscle Laminopathies"],"prefix":"10.3390","volume":"9","author":[{"given":"D\u00e9borah","family":"Cardoso","sequence":"first","affiliation":[{"name":"INSERM, Institute of Myology, Center of Research in Myology, Sorbonne University, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-9275","authenticated-orcid":false,"given":"Antoine","family":"Muchir","sequence":"additional","affiliation":[{"name":"INSERM, Institute of Myology, Center of Research in Myology, Sorbonne University, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"16321","DOI":"10.1016\/S0021-9258(19)85424-8","article-title":"Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C","volume":"268","author":"Lin","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12135","DOI":"10.1016\/S0021-9258(18)37903-1","article-title":"Nuclear lamina heterogeneity in mammalian cells. Differential expression of the major lamins and variations in lamin B phosphorylation","volume":"263","author":"Worman","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5483\/BMBRep.2018.51.7.113","article-title":"Laminopathies; Mutations on single gene and various human genetic diseases","volume":"51","author":"Kang","year":"2018","journal-title":"BMB Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant Emery-Dreifuss muscular dystrophy","volume":"21","author":"Bonne","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3389\/fphys.2018.01533","article-title":"The Pathogenesis and Therapies of Striated Muscle Laminopathies","volume":"9","author":"Brull","year":"2018","journal-title":"Front. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.yexcr.2007.03.028","article-title":"\u201cLaminopathies\u201d: A wide spectrum of human diseases","volume":"313","author":"Worman","year":"2007","journal-title":"Exp. Cell Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"17381","DOI":"10.1074\/jbc.C200038200","article-title":"Structure of the Globular Tail of Nuclear Lamin","volume":"277","author":"Werner","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0969-2126(02)00777-3","article-title":"The Ig-like Structure of the C-Terminal Domain of Lamin A\/C, Mutated in Muscular Dystrophies, Cardiomyopathy, and Partial Lipodystrophy","volume":"10","author":"Krimm","year":"2002","journal-title":"Structure"},{"key":"ref_10","first-page":"293","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin A Truncation in Hutchinson-Gilford Progeria","volume":"300","author":"Bernard","year":"2003","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1042\/BST20170141","article-title":"Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome","volume":"45","author":"Strandgren","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.celrep.2012.05.015","article-title":"Unique Preservation of Neural Cells in Hutchinson- Gilford Progeria Syndrome Is Due to the Expression of the Neural-Specific miR-9 MicroRNA","volume":"2","author":"Nissan","year":"2012","journal-title":"Cell Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1212\/WNL.11.8.734","article-title":"Survival in X-chromosomal muscular dystrophy","volume":"11","author":"Dreifuss","year":"1961","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/302869","article-title":"Different Mutations in the LMNA Gene Cause Autosomal Dominant and Autosomal Recessive Emery-Dreifuss Muscular Dystrophy","volume":"66","author":"Ricci","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"ref_16","first-page":"891","article-title":"Genetic localization of a newly recognized autosomal dominant limb-girdle muscular dystrophy with cardiac involvement (LGMD1B) to chromosome 1q11-21","volume":"60","author":"Ledderhof","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/hmg\/9.9.1453","article-title":"Identification of mutations in the gene encoding lamins A\/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B)","volume":"9","author":"Muchir","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.21417","article-title":"De novoLMNAmutations cause a new form of congenital muscular dystrophy","volume":"64","author":"Mbieleu","year":"2008","journal-title":"Ann. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense Mutations in the Rod Domain of the Lamin A\/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Maggi, L., Carboni, N., and Bernasconi, P. (2016). Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features. Cells, 5.","DOI":"10.3390\/cells5030033"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.tibs.2004.01.007","article-title":"The new life of a centenarian: Signalling functions of NAD(P)","volume":"29","author":"Berger","year":"2004","journal-title":"Trends Biochem. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cmet.2018.02.011","article-title":"Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence","volume":"27","author":"Rajman","year":"2018","journal-title":"Cell Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/er.2009-0026","article-title":"The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways","volume":"31","author":"Houtkooper","year":"2010","journal-title":"Endocr. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.celrep.2018.09.091","article-title":"Alpha-Amino-Beta-Carboxy-Muconate-Semialdehyde Decarboxylase Controls Dietary Niacin Requirements for NAD+ Synthesis","volume":"25","author":"Palzer","year":"2018","journal-title":"Cell Rep."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arr.2018.05.006","article-title":"NAD metabolism: Implications in aging and longevity","volume":"47","author":"Yaku","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/ja01288a509","article-title":"Relation of nicotinic acid and nicotinic acid amide to canine black tongue","volume":"59","author":"Elvehjem","year":"1937","journal-title":"J. Am. Chem. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"50754","DOI":"10.1074\/jbc.M408388200","article-title":"The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells","volume":"279","author":"Revollo","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_28","first-page":"135","article-title":"Enzymology of Nad+Synthesis","volume":"73","author":"Magni","year":"2006","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.nutr.28.061807.155443","article-title":"Nicotinic Acid, Nicotinamide, and Nicotinamide Riboside: A Molecular Evaluation of NAD+Precursor Vitamins in Human Nutrition","volume":"28","author":"Bogan","year":"2008","journal-title":"Annu. Rev. Nutr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.foodchem.2016.10.032","article-title":"Simultaneous quantitation of nicotinamide riboside, nicotinamide mononucleotide and nicotinamide adenine dinucleotide in milk by a novel enzyme-coupled assay","volume":"221","author":"Ummarino","year":"2017","journal-title":"Food Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13103","DOI":"10.1038\/ncomms13103","article-title":"NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells","volume":"7","author":"Ratajczak","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity","volume":"15","author":"Houtkooper","year":"2012","journal-title":"Cell Metab."},{"key":"ref_33","first-page":"166","article-title":"Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?.","volume":"64","author":"Auwerx","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1101\/gad.335109.119","article-title":"Interplay between compartmentalized NAD+ synthesis and consumption: A focus on the PARP family","volume":"34","author":"Cohen","year":"2020","journal-title":"Genes Dev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0006-291X(63)90024-X","article-title":"Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme","volume":"11","author":"Chambon","year":"1963","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.tibs.2009.12.003","article-title":"Toward a unified nomenclature for mammalian ADP-ribosyltransferases","volume":"35","author":"Hottiger","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj3420249","article-title":"Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions","volume":"342","author":"Desnoyers","year":"1999","journal-title":"Biochem. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1093\/nar\/gkg761","article-title":"A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage","volume":"31","author":"Masutani","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_39","first-page":"913","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1101\/gad.334284.119","article-title":"The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation, and metabolism","volume":"34","author":"Bai","year":"2020","journal-title":"Genes Dev."},{"key":"ref_41","unstructured":"Gupte, R., Liu, Z., and Kraus, W.L. (2020, September 10). PARPs and ADP-Ribosylation: Recent Advances Linking Molecular Functions to Biological Outcomes, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5322727\/."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.semcdb.2016.07.027","article-title":"Poly ADP-ribose polymerase-1: Beyond transcription and towards differentiation","volume":"63","author":"Jubin","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2174\/1389203717666160419144959","article-title":"Poly(ADP-ribose) polymerases in aging\u2014friend or foe?.","volume":"17","author":"Vida","year":"2016","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4023","article-title":"Pharmacological approaches to restore mitochondrial function","volume":"12","author":"Andreux","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MOL.0b013e328328d0a4","article-title":"PGC-1\u03b1, SIRT1 and AMPK, an energy sensing network that controls energy expenditure","volume":"20","author":"Auwerx","year":"2009","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cmet.2010.02.006","article-title":"Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle","volume":"11","author":"Jiang","year":"2010","journal-title":"Cell Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/07853890701408194","article-title":"Sirtuins: The \u2018magnificent seven\u2019, function, metabolism and longevity","volume":"39","author":"Lagouge","year":"2007","journal-title":"Ann. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"927","DOI":"10.14336\/AD.2019.0820","article-title":"Sirtuins and their Biological Relevance in Aging and Age-Related Diseases","volume":"11","author":"Zhao","year":"2020","journal-title":"Aging Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"110434","DOI":"10.1016\/j.plantsci.2020.110434","article-title":"Review: The plant sirtuins","volume":"293","author":"Zheng","year":"2020","journal-title":"Plant Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"44480","DOI":"10.1074\/jbc.M111.307645","article-title":"Connexin-43 Hemichannels Mediate Cyclic ADP-ribose Generation and Its Ca2+-mobilizing Activity by NAD+\/Cyclic ADP-ribose Transport","volume":"286","author":"Song","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E6271","DOI":"10.1073\/pnas.1601506113","article-title":"SARM1-specific motifs in the TIR domain enable NAD+ loss and regulate injury-induced SARM1 activation","volume":"113","author":"Summers","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2174\/0929867043455602","article-title":"Biochemistry, biology, and pharmacology of cyclic adenosine diphosphoribose (cADPR)","volume":"11","author":"Guse","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/BST0350109","article-title":"Regulation of calcium signalling by adenine-based second messengers","volume":"35","author":"Fliegert","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18881","DOI":"10.1074\/jbc.M111773200","article-title":"Manipulation of a Nuclear NAD+Salvage Pathway Delays Aging without Altering Steady-state NAD+Levels","volume":"277","author":"Anderson","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_55","first-page":"181","article-title":"Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae","volume":"423","author":"Anderson","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"27810","DOI":"10.1074\/jbc.M804681200","article-title":"Life Span Extension and Neuronal Cell Protection by Drosophila Nicotinamidase","volume":"283","author":"Balan","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_57","first-page":"113","article-title":"Nutrient control of glucose homeostasis through a complex of PGC-1\u03b1 and Sirtnat","volume":"434","author":"Rodgers","year":"2005","journal-title":"Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"16456","DOI":"10.1074\/jbc.M501485200","article-title":"SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1\u03b1","volume":"280","author":"Nemoto","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1126\/science.1101731","article-title":"Nutrient Availability Regulates SIRT1 Through a Forkhead-Dependent Pathway","volume":"306","author":"Nemoto","year":"2004","journal-title":"Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1210\/en.2009-1013","article-title":"Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1+\/\u2212 Mice: A Role of Lipid Mobilization and Inflammation","volume":"151","author":"Xu","year":"2010","journal-title":"Endocrinology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.cmet.2009.02.006","article-title":"Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation","volume":"9","author":"Purushotham","year":"2009","journal-title":"Cell Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI46243","article-title":"Hepatic Sirt1 deficiency in mice impairs mTorc2\/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance","volume":"121","author":"Wang","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2008.08.014","article-title":"SirT1 Gain of Function Increases Energy Efficiency and Prevents Diabetes in Mice","volume":"8","author":"Banks","year":"2008","journal-title":"Cell Metab."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9793","DOI":"10.1073\/pnas.0802917105","article-title":"Sirt1 protects against high-fat diet-induced metabolic damage","volume":"105","author":"Pfluger","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","article-title":"Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice","volume":"14","author":"Yoshino","year":"2011","journal-title":"Cell Metab."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cmet.2011.03.004","article-title":"PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation","volume":"13","author":"Bai","year":"2011","journal-title":"Cell Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2016.08.024","article-title":"Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease","volume":"66","author":"Gariani","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.3882","article-title":"Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization","volume":"21","author":"Hong","year":"2015","journal-title":"Nat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: Progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI0216783","article-title":"Deciphering the genesis and fate of amyloid \u03b2-protein yields novel therapies for Alzheimer disease","volume":"110","author":"Selkoe","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1126\/science.aac4854","article-title":"NAD+ in aging, metabolism, and neurodegeneration","volume":"350","author":"Verdin","year":"2015","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer\u2019s Disease: Cellular and Molecular Mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","article-title":"NAD+ supplementation normalizes key Alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency","volume":"115","author":"Hou","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/j.celrep.2017.08.022","article-title":"Deletion of Nampt in Projection Neurons of Adult Mice Leads to Motor Dysfunction, Neurodegeneration, and Death","volume":"20","author":"Wang","year":"2017","journal-title":"Cell Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1073\/pnas.1213956109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease","volume":"109","author":"Xu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.1213960109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis","volume":"109","author":"Tesla","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ng.2356","article-title":"Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration","volume":"44","author":"Koenekoop","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.celrep.2016.08.073","article-title":"NAMPT-Mediated NAD(+) Biosynthesis Is Essential for Vision In Mice","volume":"17","author":"Lin","year":"2016","journal-title":"Cell Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1126\/science.aal0092","article-title":"Vitamin B3modulates mitochondrial vulnerability and prevents glaucoma in aged mice","volume":"355","author":"Williams","year":"2017","journal-title":"Science"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.trecan.2017.06.001","article-title":"NAD + Deficits in Age-Related Diseases and Cancer","volume":"3","author":"Garrido","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BST20180417","article-title":"Keeping the balance in NAD metabolism","volume":"47","author":"Niere","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_82","first-page":"100664","article-title":"Effect of genetic background on the cardiac phenotype in a mouse model of Emery-Dreifuss muscular dystrophy","volume":"19","author":"Vignier","year":"2019","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/hmg\/ddi017","article-title":"Mouse model carrying H222P- Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies","volume":"14","author":"Arimura","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1093\/hmg\/ddy278","article-title":"Rescue of biosynthesis of nicotinamide adenine dinucleotide protects the heart in cardiomyopathy caused by lamin A\/C gene mutation","volume":"27","author":"Vignier","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.cell.2013.06.016","article-title":"The NAD+\/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling","volume":"154","author":"Mouchiroud","year":"2013","journal-title":"Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.cmet.2013.07.002","article-title":"Mitochondrial Complex I Deficiency Increases Protein Acetylation and Accelerates Heart Failure","volume":"18","author":"Karamanlidis","year":"2013","journal-title":"Cell Metab."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1074\/jbc.M109.077271","article-title":"Exogenous NAD Blocks Cardiac Hypertrophic Response via Activation of the SIRT3-LKB1-AMP-activated Kinase Pathway","volume":"285","author":"Pillai","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1161\/CIRCULATIONAHA.116.026099","article-title":"Nicotinamide riboside preserves cardiac function in a mouse model of dilated cardiomyopathy","volume":"137","author":"Diguet","year":"2017","journal-title":"Circulation"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/CIRCULATIONAHA.116.022495","article-title":"Normalization of NAD + Redox Balance as a Therapy for Heart Failure","volume":"134","author":"Lee","year":"2016","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1093\/hmg\/ddz056","article-title":"Alteration of performance in a mouse model of Emery\u2013Dreifuss muscular dystrophy caused by A-type lamins gene mutation","volume":"28","author":"Thomasson","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"361ra139","DOI":"10.1126\/scitranslmed.aaf5504","article-title":"NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation","volume":"8","author":"Ryu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cmet.2016.07.005","article-title":"Loss of NAD Homeostasis Leads to Progressive and Reversible Degeneration of Skeletal Muscle","volume":"24","author":"Frederick","year":"2016","journal-title":"Cell Metab."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., and Sadoshima, J. (2014). Nicotinamide Mononucleotide, an Intermediate of NAD+ Synthesis, Protects the Heart from Ischemia and Reperfusion. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098972"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.celrep.2015.09.023","article-title":"Lethal Cardiomyopathy in Mice Lacking Transferrin Receptor in the Heart","volume":"13","author":"Xu","year":"2015","journal-title":"Cell Rep."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","article-title":"Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B","volume":"6","author":"Khan","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"12948","DOI":"10.1038\/ncomms12948","article-title":"Nicotinamide riboside is uniquely and orally bioavailable in mice and humans","volume":"7","author":"Trammell","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molmet.2019.09.013","article-title":"A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor","volume":"30","author":"Joffraud","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.07.040","article-title":"P7C3 Neuroprotective Chemicals Function by Activating the Rate-Limiting Enzyme in NAD Salvage","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1038\/s41467-019-11078-z","article-title":"Boosting NAD+ with a small molecule that activates NAMPT","volume":"10","author":"Gardell","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/acs.jmedchem.7b01254","article-title":"\u03b1-Amino-\u03b2-carboxymuconate-\u03b5-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis","volume":"61","author":"Pellicciari","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_101","first-page":"354","article-title":"De novo NAD+ synthesis enhances mitochondrial function and improves health","volume":"563","author":"Katsyuba","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cmet.2019.05.015","article-title":"Extracellular Vesicle-Contained eNAMPT Delays Aging and Extends Lifespan in Mice","volume":"30","author":"Yoshida","year":"2019","journal-title":"Cell Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yjmcc.2017.09.001","article-title":"Short-term administration of Nicotinamide Mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure","volume":"112","author":"Zhang","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.1038\/srep15857","article-title":"Monocyte-derived extracellular Nampt-dependent biosynthesis of NAD+ protects the heart against pressure overload","volume":"5","author":"Yano","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"13148","DOI":"10.1074\/jbc.M111469200","article-title":"Structure of Human Nicotinamide\/Nicotinic Acid Mononucleotide Adenylyltransferase","volume":"277","author":"Zhou","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"36334","DOI":"10.1074\/jbc.M508660200","article-title":"Subcellular Compartmentation and Differential Catalytic Properties of the Three Human Nicotinamide Mononucleotide Adenylyltransferase Isoforms","volume":"280","author":"Berger","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/carcin\/bgx137","article-title":"CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells","volume":"39","author":"Bu","year":"2017","journal-title":"Carcinogenesis"},{"key":"ref_108","first-page":"1386","article-title":"Regulation of intracellular levels of NAD: A novel role for Cdbiochem. Biophys","volume":"345","author":"Aksoy","year":"2006","journal-title":"Res. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2018.02.015","article-title":"Genetic deletion of CD38 confers post-ischemic myocardial protection through preserved pyridine nucleotides","volume":"118","author":"Boslett","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1016\/j.bmcl.2011.05.022","article-title":"Flavonoids as inhibitors of human Cdbioorganic","volume":"21","author":"Kellenberger","year":"2011","journal-title":"Med. Chem. Lett."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db12-1139","article-title":"Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD: Implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome","volume":"62","author":"Escande","year":"2013","journal-title":"Diabetes"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3945\/ajcn.114.098590","article-title":"Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: A randomized, double-blind, placebo-controlled, crossover trial","volume":"101","author":"Dower","year":"2015","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1101\/gad.334516.119","article-title":"PARP and PARG inhibitors in cancer treatment","volume":"34","author":"Slade","year":"2020","journal-title":"Genes Dev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2337\/db13-1364","article-title":"MicroRNA-149 Inhibits PARP-2 and Promotes Mitochondrial Biogenesis via SIRT-1\/PGC-1\u03b1 Network in Skeletal Muscle","volume":"63","author":"Mohamed","year":"2014","journal-title":"Diabetes"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.bbrc.2012.11.132","article-title":"PARP-2 knockdown protects cardiomyocytes from hypertrophy via activation of SIRT1","volume":"430","author":"Geng","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2248\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:17:11Z","timestamp":1760177831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/10\/2248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":115,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["cells9102248"],"URL":"https:\/\/doi.org\/10.3390\/cells9102248","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]}}}